🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be a double-blind, placebo-controlled, parallel group study...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-01-07
Trial ID
NCT01110057
In this randomized, double-blind, multi-centre, placebo controlled, explora...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-09-25
Trial ID
NCT00976560
This study is designed to look at the safety, tolerability and effectivenes...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10
Trial ID
NCT00393146
Treatments Being Tested
The main purpose of this study is to determine the effect of Losmapimod on ...
Status
Completed
Location
Cambridge University Hospitals NHS Foundation Trust
Start Date
2012-06
Trial ID
NCT01541852
Treatments Being Tested
This study is being conducted to measure the amount of study drug that is i...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-08
Trial ID
NCT00517543
Treatments Being Tested
This study will be a double-blind, placebo-controlled, parallel group study...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08
Trial ID
NCT00969059
This study is being conducted to assess the potential anti-inflammatory eff...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-06-02
Trial ID
NCT00633022
Treatments Being Tested
This is a randomised, double-blind, parallel-group, multi-centre study eval...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-09
Trial ID
NCT02299375
Treatments Being Tested
This will be a double-blind, 4-period, randomized, cross-over study conduct...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-10
Trial ID
NCT01756495
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel group, mul...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-08
Trial ID
NCT00910962